|
Regeneron Pharmaceuticals Inc - Premium Company Profile (Datamonitor)
Market: Healthcare and Medical
Published Date: 24/12/2007
Market Research Report Title: Regeneron Pharmaceuticals Inc - Premium Company Profile
Table of Contents: View
Report Type: Company Profile
Country: Global
Number of Pages: 51
|
Enquire about Report |
Summary: Introduction
Regeneron Pharmaceuticals is a biopharmaceutical company mainly focused on the development and commercialization of products for oncology, age-related macular degeneration (AMD), and autoimmune diseases. The company is developing its drugs using its Trap technology, which is designed to block key cytokine targets in order to treat disease.
Scope
Contains corporate strategy, value chain presence and SWOT AnalysisProvides detailed business description, segment analysis, 5-year financial trends, key products and key competitorsIncludes information on suppliers/ partners, shareholding structure and key employees with biographiesHighlights
Regeneron Pharmaceuticals discovers, develops, and intends to commercialize therapeutic medicines for the treatment of serious medical conditions. Regeneron has therapeutic candidates for the potential treatment of cancer, eye diseases, and inflammatory diseases and has preclinical programs in other diseases and disorders.The company derives all of its revenues from contract manufacturing, research and development payments from collaborators and licensing of products. Its total revenues increased at a CAGR of 30% during 2002-2006, from $22 million to $63 million.Regeneron Pharmaceuticals′s total revenues are forecast to increase at a CAGR of 57% from $51 million to $308 million during 2006-2010, representing an absolute growth of +$257 million. The increase in contract and collaborative revenues is due to the advancement of product candidates under collaborations with Bayer Healthcare and Sanofi-Aventis.Reasons to Purchase
Access all the important information and analysis on the company in a single reportUnderstand company′s strengths, weaknesses, opportunities and threats along with business strategy and value chainGain access to company′s adjusted five year financial data along with key ratios and market capitalization
Reports are normally delivered on the same day, via email, if purchased by debit/credit card. Reports purchased by invoice will be released when payment has been received. When you place an order through Google Checkout, Google Checkout will display a price approximation in your local currency. Keep in mind that you'll still be charged in the currency displayed on companiesandmarkets.com. Your debit/credit card company might convert the charge to your local currency and may also add additional fees that are not reflected in the approximate price displayed.
www.companiesandmarkets.com is a central source of market research reports from the world’s leading analysts and report publishers. Companiesandmarkets.com contains a comprehensive range of specialised market research reports from leading publishers for all market sectors.
